Efpeglenatide lowers CV and kidney disease risk in high-risk diabetes patients: Study Medha Baranwal10 July 2021 10:15 AM ISTThe cardiovascular and renal benefits occurred independently of the baseline use of SGLT2 inhibitors, the baseline use of metformin, and the baseline...
Earlier Blood sugar control in Diabetes lowers risk of death and heart attack: Study Dr. Kamal Kant Kohli9 July 2021 11:30 AM ISTEarlier blood sugar control in Diabetes type 2 patients prevents them from heart attack and death, finds a joint study from the Universities of...
Hospitalization for diabetes in children doubled during COVID-19 pandemic: Study Hina Zahid7 July 2021 9:00 AM ISTThe findings reinforces the importance of maintaining a healthy lifestyle for children even under such difficult circumstances of COVID-19...
Pulsatile insulin infusion improves kidney function, BP and patient satisfaction in diabetes: Study Dr. Nandita Mohan6 July 2021 9:00 AM ISTimprovement of kidney function, systolic blood pressure, and treatment satisfaction in patients with type 2 diabetes
Time-Restricted Eating May Reduce Diabetes-Related Hypertension: Study Hina Zahid5 July 2021 9:24 PM ISTLEXINGTON, Ky. -Time-restricted eating may be able to help people with Type 2 diabetes reduce nocturnal hypertension, which is characterized by...
SGLT2 inhibitors better than sulfonylureas for reducing deaths in type 2 diabetes: JAMA Medha Baranwal5 July 2021 11:45 AM ISTSt Louis, Missouri: The use of SGLT2 inhibitors may reduce the risk of all-cause mortality compared with sulfonylureas in patients with type 2...
Urinary podocin early marker of diabetic nephropathy in T2D, finds study Dr Satabdi Saha5 July 2021 9:00 AM ISTThe urinary podocin can serve as an early marker for diabetic nephropathy as well as a marker of disease progression and severity among...
SGLT2 inhibitors cause double weight loss than GLP-1 receptor agonists in diabetics: Study Hina Zahid3 July 2021 10:30 AM ISTAmong 72 patients, people using SGLT2 inhibitors experienced a median weight loss of more than 6 pounds, while those on GLP-1 receptor agonists lost a...
Variability in fasting blood sugar levels linked to NAFLD development: Study Medha Baranwal2 July 2021 11:45 AM ISTKorea: Patients with increased long-term fasting plasma glucose (FPG) variability are at increased risk of nonalcoholic fatty liver disease (NAFLD)...
SGLT-2 Inhibitors may Improve Endothelial Function in T2D with CVD: Study Dr Kartikeya Kohli2 July 2021 9:00 AM ISTEmpagliflozin treatment has potential to improve endothelial function and has cardiovascular benefits, finds new study.
Finerenone improves kidney outcomes in patients of CKD with diabetes: Study Medha Baranwal2 July 2021 9:00 AM ISTDelhi: Finerenone exerts renoprotective benefits in patients with chronic kidney disease (CKD) and type 2 diabetes (T2D) irrespective of absence or...
T2D patients more at risk of diabetic ketoacidosis related mortality compared to T1D patients: Study Dr Satabdi Saha1 July 2021 11:15 AM ISTAccording to recent research report published in The Journal of Investigative Medicine, the rate of mortality resulting from diabetic...
